Drug Shortage Report for CALCIUM GLUCONATE INJECTION, USP 10%

Last updated on 2021-11-16 History
Report ID 147629
Drug Identification Number 02141019
Brand name CALCIUM GLUCONATE INJECTION, USP 10%
Common or Proper name Calcium Gluconate Injection, USP 10% 100 mg/mL SD Vial (Plastic) 50 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) CALCIUM GLUCONATE
Strength(s) 100MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 50 mL
ATC code B05BB
ATC description I.V. SOLUTIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2021-11-01
Actual start date 2021-11-01
Estimated end date 2021-12-31
Actual end date
Shortage status Actual shortage
Updated date 2021-11-16
Company comments Allocation strategy implemented to stretch inventory and ensure equitable distribution. Please see customer communication.
Health Canada comments
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2021-11-16 French Compare
v7 2021-11-16 English Compare
v6 2021-11-02 English Compare
v5 2021-10-20 French Compare
v4 2021-10-20 English Compare
v3 2021-10-20 French Compare
v2 2021-10-20 English Compare
v1 2021-10-20 English Compare